{"basic_info": {"ticker": "1875", "exchange": "XHKG", "bloomberg_ticker": "1875 HK Equity", "name": "TOT BIOPHARM INTERNATIONAL C", "industry": "Biotechnology", "name_chinese_simplified": "东曜药业", "period": "2020", "market_value": 2672076800, "total_income": 22491000, "ccy": "人民币元", "shariah_compliance_summary": "unknown"}, "business_activity_screening": {"summary": [{"shariah_compliance": "compliant", "income": 521000, "business_income_over_total_income": 0.023164821484149216}, {"shariah_compliance": "unknown", "income": 21970000, "business_income_over_total_income": 0.9768351785158509}], "details": [{"business_activity_cn": "佣金收益", "business_activity_en": "Commission income", "income": 14703000, "business_income_over_total_income": 0.6537281579298386, "shariah_compliance": "unknown"}, {"business_activity_cn": "CMO", "business_activity_en": "CMOs", "income": 0, "business_income_over_total_income": 0.0, "shariah_compliance": "unknown"}, {"business_activity_cn": "商品销售", "business_activity_en": "Merchandising", "income": 521000, "business_income_over_total_income": 0.023164821484149216, "shariah_compliance": "compliant"}, {"business_activity_cn": "其他", "business_activity_en": "other", "income": 45000, "business_income_over_total_income": 0.0020008003201280513, "shariah_compliance": "unknown"}, {"business_activity_cn": "CDMO", "business_activity_en": "CDMO", "income": 6423000, "business_income_over_total_income": 0.2855808990262772, "shariah_compliance": "unknown"}, {"business_activity_cn": "CRO收益", "business_activity_en": "CRO earnings", "income": 799000, "business_income_over_total_income": 0.03552532123960695, "shariah_compliance": "unknown"}, {"business_activity_cn": "未分配", "business_activity_en": "Unassigned", "income": 0, "business_income_over_total_income": 0.0, "shariah_compliance": "unknown"}]}, "financial_screening": [{"item": "Debt to Market Capitalization", "amount": 0.003208109242264402, "shariah_compliance": "compliant", "amount_over_market_value": 0.003208109242264402}]}